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We previously identified a series of inositol polyphosphate kinases (IPKs), Arg1, Ipk1, 
Kcs1 and Asp1, in the opportunistic fungal pathogen Cryptococcus neoformans. Using 
gene deletion analysis, we characterized Arg1, Ipk1 and Kcs1 and showed that they act 
sequentially to convert IP3 to PP-IP5 (IP7), a key metabolite promoting stress tolerance, 
metabolic adaptation and fungal dissemination to the brain. We have now directly 
characterized the enzymatic activity of Arg1, demonstrating that it is a dual specificity 
(IP3/IP4) kinase producing IP5. We showed previously that IP5 is further phosphorylated 
by Ipk1 to produce IP6, which is a substrate for the synthesis of PP-IP5 by Kcs1. 
Phenotypic comparison of the arg1Δ and kcs1Δ deletion mutants (both PP-IP5-deficient) 
reveals that arg1Δ has the most deleterious phenotype: while PP-IP5 is essential for 
metabolic and stress adaptation in both mutant strains, PP-IP5 is dispensable for 
virulence-associated functions such as capsule production, cell wall organization, and 
normal N-linked mannosylation of the virulence factor, phospholipase B1, as these 
phenotypes were defective only in arg1Δ. The more deleterious arg1Δ phenotype 
correlated with a higher rate of arg1Δ phagocytosis by human peripheral blood 
monocytes and rapid arg1Δ clearance from lung in a mouse model. This observation is 
in contrast to kcs1Δ, which we previously reported establishes a chronic, confined lung 
infection. In summary, we show that Arg1 is the most crucial IPK for cryptococcal 
virulence, conveying PP-IP5–dependent and novel PP-IP5–independent functions. 
Introduction 
Cryptococcus neoformans is a major opportunistic fungal pathogen in 
immunocompromised individuals, especially those with HIV/AIDS (reviewed in 1, 2, 3). 
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Although the primary site of infection is the lung, immunosuppressed patients typically 
present with meningoencephalitis, which is fatal without treatment 1, 2, 3. Even with 
appropriate treatment, (amphotericin B and 5 flucytosine, followed by long-term 
fluconazole), unacceptably high mortalities are reported 1, 2, 3, highlighting the need to 
develop more effective antifungal therapies. Current drugs target the ergosterol 
biosynthetic pathway/cell membrane (azoles, amphotericin B), RNA (5 flucytosine) or 
the cell wall biosynthetic enzyme, glucan 3 synthase (echinocandins). Amphotericin B 
exhibits significant haematological and nephrological toxicity 4, while echinocandins are 
ineffective against the Cryptococcus complex 5 6. Furthermore, fluconazole-resistant C. 
neoformans has been reported in Sub-Saharan Africa and South East Asia 7 8. A 
detailed understanding of the biology of C. neoformans and other pathogenic fungi is 
essential for the identification of new drug targets.  
 
The ability of C. neoformans to adapt to the host environment is mediated by several 
key signalling pathways (reviewed in 9). These pathways also fine-tune secretory 
mechanisms to facilitate export of virulence factors and cell wall remodelling enzymes 10 
11 12. Secreted virulence factors include the cell-wall associated enzyme, laccase 
(produces melanin) 13, the cell wall-associated and secreted invasin, phospholipase B1 
(Plb1) 14, and polysaccharide capsule building blocks15, 16 which attach to the cell wall 17, 
18. Secretion is therefore essential for regulating fungal virulence and surface 
architecture, the latter of which impacts recognition by the innate immune system 19.  
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Using a combination of gene deletion analysis, inositol polyphosphate (IP) and 
phenotype profiling and enzyme activity assays, we identified and characterised the 
phospholipase C1/inositol polyphosphate kinase (Plc1/IPK) pathway, and showed that it 
is essential for the production of several virulence traits and for regulating cell wall 
integrity. Specifically, we showed that Plc1, the homologue of the PLC1δ isoform in 
mammalian cells, hydrolyzes the membrane phospholipid, phosphatidylinositol 4,5-
bisphosphate (PIP2) to generate inositol 1,4,5-trisphosphate (IP3) 20. Several IPK 
enzymes, i.e. Arg1, Ipk1, Kcs1 and Asp1, then act sequentially to generate a series of 
IPs and inositol pyrophosphates (PP-IPs).  
 
IPs and PP-IPs are present in all eukaryotes and play critical roles in cellular function 
(reviewed in 21, 22). Several lines of evidence support fungal IPKs as being candidate 
targets for antifungal drug development. Firstly, the IPK pathway is non-linear and more 
complex in mammalian cells than it is in fungi, and generates a wider variety of IP 
species. Secondly, some mammalian enzymes exhibit functional redundancy, e.g. 
inositol polyphosphate multikinase (IPMK) and IP3K both convert IP3 to IP4. In contrast, 
each IP conversion step in C. neoformans is catalyzed by a single IPK. Thirdly, IPKs 
share a low sequence homology with their mammalian counterparts (e.g. human IPMK 
and C. neoformans Arg1 are only 19% identical). Finally, a homology search reveals 
that IPKs are also non-redundant in other fungal pathogens, for example Candida 
albicans, suggesting that IPKs are a possible target for panfungal therapy.   
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The first IP produced by the Plc1/IPK pathway is IP3, which we showed serves as a 
substrate for Arg1 20. In comparison with WT, IP3 accumulated in the ARG1 deletion 
mutant (arg1Δ), whereas all IP and PP-IP species downstream of IP3 were depleted, 
confirming, indirectly, that Arg1 is an IP3 kinase 23. We also identified a homolog of Arg1 
in the cryptococcal genome, Arg2, but found that it neither played a role in IP3 
conversion nor in virulence 20. Ipk1, Kcs1, and Asp1 were later identified as IP5, IP6 and 
PP-IP5 kinases, respectively, acting downstream of Arg1 23, 24.  
Phenotypic characterization of the arg1Δ mutant demonstrated that Arg1 is essential for 
thermotolerance, cell wall integrity and vacuolar homeostasis 20. The arg1Δ mutant was 
also hypovirulent in a Galleria melonella infection model 20. In contrast, the terminal IPK, 
Asp1, and its product, (PP)2-IP4, were dispensable for cellular function and virulence 23. 
Using the kcs1Δ mutant, which is deficient in PP-IP5 and (PP)2-IP4, we showed that PP-
IP5 is crucial for cell wall integrity, response to stress, metabolic adaptation to the 
utilization of diverse carbon sources and dissemination of infection in a mouse 
inhalation model 20, 23, 24. Although the ipk1Δ deletion mutant is also deficient in PP-IP5 
and IP6, attenuation of its phenotypes was not as severe as in the kcs1Δ mutant due to 
the accumulation of PP-IP4, which we concluded partially compensates for the absence 
of PP-IP5 24. Similar to kcs1Δ, the arg1Δ mutant does not produce PP-IP5, suggesting 
that the absence of PP-IP5 is responsible, at least in part, for the phenotypic defects of 
arg1Δ.  
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In this study we demonstrate that recombinant Arg1 is a dual specificity kinase, 
converting IP3 to IP4 and IP4 to IP5. We also perform extensive phenotypic comparison 
of the arg1Δ and kcs1Δ mutants, and identify Arg1 functions that are independent of 
PP-IP5. These functions include capsule production, N-linked mannosylation and 
secretion of the virulence determinant Plb1 and cell wall organization. We show that via 
these functions, Arg1 affects recognition of C. neoformans by the host immune system 
and its ability to establish a lung infection.  
 
Results 
 
Cryptococcal Arg1 restores defective phenotypes in the S. cerevisiae arg82Δ 
mutant.  
To assess the degree of functional similarity between Arg1 and its orthologue in S. 
cerevisiae, Arg82, we tested whether ARG1 could restore the growth defects observed 
in the S. cerevisiae arg82Δ mutant in a complementation assay. Arg82 acts as both an 
IP3 and an IP4 kinase to produce IP5. Both the arg1Δ mutant and the arg82Δ mutant 
exhibit a pleiotropic phenotype 25, 26. Phenotypes that are shared by arg1Δ and arg82Δ 
include defective mating and high temperature sensitivity 20. The arg82Δ mutant is also 
auxotrophic for arginine and ornithine 25-27. In Figure 1, we show that the introduction of 
cryptococcal ARG1 into the S. cerevisiae arg82Δ mutant restored its growth at elevated 
temperature and on ornithine as a sole nitrogen source. Furthermore, ARG1 restored 
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arg82Δ tolerance to SDS and the cell wall perturbing agent calcofluor white (CFW). 
These findings support the role of Arg1 as an IP3 and an IP4 kinase, similar to Arg82.  
 
Arg1 and Arg82 contribute differentially to stress adaptation of C. neoformans 
and S. cerevisiae, respectively. 
To compare the contribution of Arg1 and Arg82 to stress tolerance in C. neoformans 
and S. cerevisiae, respectively, the deletion mutants were exposed to elevated 
temperature and ionic stress. Figure 2 demonstrates that cryptococcal Arg1 and Kcs1 
contribute more significantly to temperature tolerance in C. neoformans than Arg82 and 
Kcs1 do in S. cerevisiae. However, in contrast to Arg82 and Kcs1 in S. cerevisiae, 
cryptococcal Arg1 and Kcs1 contribute very little to adaptation to ionic stress in C. 
neoformans. 
 
Recombinant Arg1 has IP3 and IP4 kinase activities  
In our previous study, we used HPLC-based IP profiling of WT and arg1Δ to 
demonstrate indirectly that Arg1 is an IP3 kinase:  the arg1Δ mutant accumulated IP3, 
while IP4-6, PP-IP5 and (PP)2-IP4 were absent 23. To obtain direct evidence that, similar 
to Arg82, Arg1 has both IP3 and IP4 kinase activities, we produced recombinant His-
tagged Arg1 in E. coli (Figure 3A). We found that overnight induction of His-Arg1 
expression at 22°C resulted in the highest yield of soluble, full-length fusion protein. The 
enzyme was then purified in two steps using cobalt affinity and anion exchange 
chromatography.   
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To establish IP5 as the end-product of Arg1 catalysis, purified enzyme (final 
concentration 5 ng/μl) was incubated with IP3 and ATP for 20 min and 2 hours. 
Phosphorylation products were analyzed by polyacrylamide gel electrophoresis followed 
by Toluidine Blue staining. The results in Figure 3B demonstrate the complete 
conversion of IP3 to IP5 by Arg1 in 20 minutes. A faint band migrating at a rate similar to 
that of IP6 was observed in both Arg1 reactions. This band is most likely PP-IP4, which 
is also a product of purified IPMK 28. To confirm IP4 as the intermediate product in Arg1-
mediated IP5 production, purified Arg1 at different concentrations (1-10 ng/μl) was 
incubated with IP3 and ATP for 10 minutes. The results in Figure 3B demonstrate direct 
correlation between the amount of Arg1 and the amount of IP4 and IP5 produced, 
establishing Arg1 as a dual specificity (IP3 and IP4) kinase.  
To determine the kinetic properties of Arg1, we used a bioluminescent assay to quantify 
Arg1-mediated ATP consumption (Figure 3C). The Km of Arg1 for ATP was estimated to 
be 184 μM and the Vmax 2.35 μM/min. 
  
Sensitivity of cryptococcal arg1Δ and kcs1Δ to nutrient and cell wall stress 
highlights the importance of PP-IP5 for stress adaptation 
We previously described the defective phenotype of the arg1Δ mutant 20. To distinguish 
PP-IP5-dependent and -independent defects, we performed a comprehensive 
phenotypic comparison of the arg1Δ and kcs1Δ mutants using drop dilution assays 
(Figure 4). The results demonstrate that both mutants are hypersusceptible to multiple 
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stress conditions including alkaline pH, cell wall perturbing agents and ER stress 
(tunicamycin and DTT). Growth of both mutants was also slower on blood agar, on 
carbon sources other than glucose, in an environment deficient in free phosphate and at 
high temperature (37°C). At 37°C, arg1Δ growth was more severely compromised than 
kcs1Δ growth, while under cell culture conditions (37°C/5% CO2, pH 7.4), growth of 
kcs1Δ and arg1Δ was equally compromised. This was likely due to the basic pH, to 
which both mutants are equally sensitive (Figure 4). Taken together, these results 
confirm the importance of PP-IP5 in stress adaptation. 
 
arg1Δ and kcs1Δ mutants differ in cell wall organisation, vacuolar morphology 
and capsule production  
Cell wall organization: The hypersusceptibility of the arg1Δ and kcs1Δ mutants to cell 
wall perturbing agents prompted us to visualize cell wall ultrastructure using 
transmission electron microscopy (TEM). In comparison to WT and the kcs1Δ mutant, 
arg1Δ cells were often enlarged. The cell walls of the enlarged cells were disorganized 
and multi-layered (Figure 5). In WT, the cell wall thickness ranged between 100 and 150 
nm, while in the enlarged arg1Δ cells it often reached 300-500 nm. Unexpectedly, given 
that the hypersusceptibility of the kcs1Δ mutant to cell wall perturbing agents is greater 
than or equal to that of the arg1Δ mutant, the cell walls of this mutant were similar to 
those of the WT in thickness and morphology (Figure 4). 
Vacuolar morphology: Using differential interference contrast and fluorescence 
microscopy we previously demonstrated that a significant proportion of arg1Δ cells were 
D
ow
nl
oa
de
d 
by
 [U
C
L 
Li
br
ar
y 
Se
rv
ic
es
] a
t 0
0:
45
 3
0 
O
ct
ob
er
 2
01
7 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 10 
larger than those of WT, and that arg1Δ cells had enlarged vacuoles, which were likely 
to have formed by fusion of smaller vacuoles 20. We therefore used the lipophilic dye, 
FM 4-64, to label the endocytic pathway in WT, arg1Δ and kcs1Δ as described in 20. We 
found that in contrast to arg1Δ, kcs1Δ cells rarely produced enlarged vacuoles and their 
cell size was similar to that of WT (Figure 6). Images obtained by TEM (Figure 5) 
similarly show enlarged vacuoles in arg1Δ cells, as reported previously 20. 
Capsule production: Capsules were induced following growth in minimal medium, and 
visualized under the light microscope following negative staining with India Ink (Figure 
7). Statistical analysis of capsule size showed that arg1Δ capsules are smaller than 
those of WT and kcs1Δ, and that kcs1Δ capsules are larger than those of WT and 
arg1Δ. We also note that vacuoles are significantly larger in arg1Δ than in WT and 
kcs1Δ, supporting the FM 4-64 data in Figure 6.  
 
Phospholipase B1 secretion is blocked in arg1Δ  
To further investigate the differences in cell wall architecture between arg1Δ and kcs1Δ, 
we focused on the secretory pathway, which is essential for the export of 
mannoproteins involved in cell wall integrity. One of these mannoproteins is the 
virulence factor Plb1 29, 30. Not only is Plb1 a fungal ‘invasin’ with a role in cell wall 
integrity 14, it is also a marker of the classical secretion pathway in C. neoformans 31, 32. 
Plb1 acquires a glycosylphosphatidylinositol (GPI) anchor in the ER/Golgi to enable 
Plb1 attachment to the cell surface 14, 33. However, Plb1 can also become detached 
from the cell surface and released to the external milieu 14, 34. 
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The levels of secreted and cell-associated Plb1 in WT, arg1Δ and kcs1Δ were assessed 
by Western blotting with the anti-Plb1 antibody. Figure 8A demonstrates that the 
majority of Plb1 in WT samples is released extracellularly. Conversely, the arg1Δ 
mutant secreted very little Plb1 but produced more cell-associated Plb1 than WT, 
indicative of a Plb1 secretion block. In contrast, no Plb1 was detected in the secretions 
and very little Plb1 was produced intracellularly in kcs1Δ, despite the PLB1 mRNA level 
being similar to that of the WT (Fig. 8B).  
 
Plb1 is hyper N-linked mannosylated in arg1Δ but not in kcs1Δ 
In Figure 8A, we observed that Plb1 produced by arg1Δ has a higher apparent 
molecular weight on SDS-PAGE (170 kDa) than WT (120 kDa). We showed previously 
that approximately 30% of the molecular weight of Plb1 is attributable to N-linked 
mannosylation 35, and that preventing the acquisition of N-linked mannosylation by site-
directed mutagenesis prevents Plb1 transport to the cell surface in a heterologous 
expression system 30. To determine whether the increase in Plb1 size in the arg1Δ 
mutant (Figure 8A) is due to abnormal processing of N-linked mannose sugars in the 
Golgi, we treated the secretions collected from WT and arg1Δ with N-glycosidase F 
(PNGase F) and assessed protein size by anti-Plb1 Western blotting (Figure 9A). 
Secretions were chosen over cell-associated fractions as TRIzol-extracted cellular 
proteins are less amenable to enzymatic treatment due to the need to solubilize them in 
a strong detergent. Although arg1Δ secretes less Plb1 than WT, sufficient Plb1 protein 
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was present in arg1Δ secretions to observe a shift in molecular weight following 
PNGase F treatment. As shown in Figure 9A, PNGase F treatment reduced the size of 
Plb1 in both WT and arg1Δ to approximately 65 kDa, consistent with the molecular 
weight of Plb1 as deduced from its amino acid sequence. These results confirm that 
Plb1 is hyper N-mannosylated in the arg1Δ mutant.  
 
To determine whether hyper N-linked mannosylation in the arg1Δ mutant extends to all 
secreted proteins, PNGase F treated and untreated secretions were resolved by SDS-
PAGE. The gels were then stained consecutively with a glycoprotein-specific stain 
(Figure 9B) and Coomassie Blue (Figure 9C). Differences were observed in the 
glycoprotein profile of the secretomes from untreated WT and arg1Δ (Figure 9B).  
PNGase F-treated WT and arg1Δ secretomes had a fainter stain than the 
corresponding untreated sample, indicating that most of the proteins in each secretome 
are N-linked mannosylated. However, in contrast to Plb1 in Figure 9A, Coomassie 
staining unexpectedly demonstrated differences in the profiles of PNGase F-treated WT 
and arg1Δ secretions, indicating that the composition of the arg1Δ secretome is altered; 
this prevented assessment of whether N-linked mannosylation, in general, is also 
affected. Interestingly, we observed a highly abundant protein with a MW of 25 kDa in 
WT, but not arg1Δ. This protein appeared to be glycosylated as it stained strongly with 
the glycoprotein stain, but its MW was unchanged following PNGase F treatment, 
consistent with the presence of O-linked sugars. 
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Arg1 is essential for lung colonization and dissemination in a murine inhalation 
model.   
To assess the impact of ARG1 deletion on cryptococcal virulence, we compared the 
survival of mice infected with WT, arg1Δ and arg1Δ + ARG1 using the inhalation model, 
which mimics the natural route of infection in humans (Figure 10). All arg1Δ-infected 
mice were healthy and had lost no weight by 60-days post-infection. In comparison, all 
WT and arg1Δ + ARG1-infected mice succumbed to infection by day 21. The median 
survival time of the WT and arg1Δ + ARG1-infected mice was 15 and 16.5 days, 
respectively. The difference in survival of arg1Δ-infected mice versus WT- and arg1Δ + 
ARG1-infected mice was statistically significant (Figure 10A).  
 
Fungal burdens in the lung and brain of WT and arg1Δ–infected mice were also 
assessed. In contrast to kcs1Δ, which was avirulent, but established a chronic, 
localized, asymptomatic lung infection that persisted for 50-days post-inoculation 23, 
arg1Δ infection was cleared from mouse lung between 3 and 7-days post-inoculation 
(Figure 10B). Consistent with the absence of established lung infection, no arg1Δ CFUs 
were detected in the brain by day 14, which is the time when WT brain burdens were 
the highest (Figure 10B). Brain tissue harvested from arg1Δ-infected mice upon 
termination of the study at day 60 revealed no evidence of cryptococcal dissemination 
to the CNS (data not shown). Histological analysis showed that by 3-days post-
inoculation, WT cryptococci had colonized the lung parenchyma (Figure 10C). In 
contrast, only a few small acapsular cryptococci are observed in the lung parenchyma 
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of arg1Δ-infected lungs at this time point, with lung pathology appearing otherwise 
healthy.  
 
We also assessed the survival and organ burdens of mice infected with WT and arg1Δ 
in a model of disseminated cryptococcosis where mice were infected via the retro-orbital 
plexus as previously described 36. In this model, WT-infected mice all succumbed to 
infection by day 10 as previously reported 36. However, following arg1Δ infection, mice 
remained asymptomatic over a 40-day infection period and there was no evidence of 
infection in blood, spleen, lungs or brain (data not shown). 
 
Phagocytosis of arg1Δ is greater than that of kcs1Δ  
Studies in mouse infection models have demonstrated that monocytes are the first line 
of defence against C. neoformans, either containing or clearing the infection 37, 38. Given 
that the arg1Δ mutant has an altered surface (Figures 5, 7 and 9), we compared the 
phagocytosis of WT, arg1Δ and kcs1Δ by human peripheral blood monocytes (PBMCs) 
using flow cytometry. Figure 11 demonstrates that the extent of phagocytosis of arg1Δ 
was 7 and 2.5 times greater than that of kcs1Δ and WT, respectively.  
 
The PP-IP5-dependent functions of Arg1 involved in stress adaptation, and its novel PP-
IP5-independent functions relating to cell wall homeostasis, cell surface architecture and 
host recognition, are summarized in Figure 12. The combination of these functions 
contributes to the essential role of Arg1 in establishment of lung infection.  
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Discussion 
 
Arg1 is a dual-specificity IP3/IP4 kinase  
Complementation studies demonstrated functional similarities between Arg1 and the 
IP3-4 kinase in S. cerevisiae (Arg82), as expression of Arg1 in the arg82Δ mutant 
restored Arg82-dependent phenotypes. We also showed directly that recombinant Arg1 
is a dual specificity kinase that rapidly converts IP3 to IP5 (via IP4) in the presence of 
ATP. Characterization of the enzymatic properties of Arg1 determined a Km of 184 μM 
for ATP as compared to 74 μM and 17 μM for chicken GgIP3K-A and human IPMK, 
respectively 39. These values are all significantly lower than the estimated intracellular 
concentration of ATP (a1 mM), suggesting that these IP3 kinases are continuously 
occupied by ATP. In contrast to IP3 kinases, the Km of Kcs1 enzymes for ATP is in the 
millimolar range 40, 41.  The lower affinity of Kcs1 for ATP is therefore consistent with the 
biosynthesis of PP-IP5, but not IP5, being linked to the availability of cellular ATP and 
hence PP-IP5 acting as a sensor of cellular energy status 21. 
 
Similarity of the arg1Δ and kcs1Δ stress sensitivity phenotypes confirms the 
importance of PP-IP5 for stress adaptation  
Using the kcs1Δ mutant, we showed that PP-IP5 is essential for stress tolerance, 
metabolic adaptation and dissemination of infection in a mouse inhalation model 23. Our 
previous studies also showed that the arg1Δ mutant, which is deficient in all IPs 
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downstream of IP3, was defective in many cellular functions and virulence-related 
phenotypes 20. However, direct comprehensive comparison of arg1Δ and kcs1Δ 
phenotypes to assess the PP-IP5-dependent and -independent contribution of Arg1 to 
cellular function had not been undertaken. We therefore performed extensive 
phenotypic analysis of arg1Δ and kcs1Δ and demonstrated that the phenotypes of both 
mutants overlap significantly. This included hypersusceptibility to cell wall perturbing 
and other stress-inducing agents. Furthermore, the ability of arg1Δ and kcs1Δ to 
metabolize alternative carbon sources was diminished. This was supported by our 
published RNAseq data23. This data demonstrated that the expression of genes 
encoding mitochondrial enzymes essential for the utilization of alternative carbon source 
is down-regulated in arg1Δ and kcs1Δ, while the expression of glycolytic enzymes is 
increased. Given that PP-IP5 is absent in arg1Δ and kcs1Δ, the results demonstrate the 
importance of PP-IP5 for adaptation to diverse stress conditions, potentially via 
pyrophosphorylation of key regulatory proteins. In support of this, the presence of 
inositol pyrophosphates leads to a decrease in the glycolytic/mitochondrial metabolic 
ratio in S. cerevisiae. This effect is attributable, at least in part, to pyrophosphorylation 
of the major glycolytic transcription factor Gcr1: pyrophosphorylated Gcr1 binds Gcr2 
with lower affinity, leading to reduced transcription of genes encoding glycolytic 
enzymes 42. 
  
Figure 4 demonstrates that PP-IP5 is required for growth under physiological conditions 
(RPMI media, pH7.4 5%CO2/37oC). Despite this, the kcs1∆ mutant persisted in the 
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lungs of infected mice23, while arg1∆ was cleared (Figure 10). This result suggests that 
PP-IP5-independent factors contribute to arg1∆ clearance from lung in vivo.  
 
Arg1 regulates capsule production, N-linked mannosylation, secretion and cell 
wall morphology independently of PP-IP5  
We identified several phenotypes that were specifically defective in arg1Δ, but not 
kcs1Δ, and which must therefore result from factors other than the absence of PP-IP5. 
These phenotypes include diminished capsule production, hyper N-linked 
mannosylation of Plb1, that was associated with failure of its release from the cell, an 
altered general secretion profile, and cell walls with abnormal morphology. Arg1Δ was 
also more rapidly phagocytozed by monocytes than kcs1Δ. Given that cell wall integrity 
is dependent on secretory functions, such as correct mannosylation and secretion, an 
alteration in these functions in arg1Δ potentially contributes to altered cell wall 
morphology and to smaller capsules, since capsule is associated with the cell wall 17, 18. 
This in turn could affect recognition by the immune system. arg1Δ-specific phenotypes 
coincided with avirulence of the arg1Δ mutant in a mouse model and rapid clearance of 
arg1Δ from the lungs (Figure 10). This is in contrast to kcs1Δ, which had normal cell 
wall morphology and established a subclinical infection that was confined to the lung 23. 
It is possible that the arg1Δ mutant is rapidly cleared from the lung because it is more 
rapidly phagocytozed by cells of the innate immune system. Reduced capsule size in 
the arg1Δ mutant is likely to expose more surface β-glucan and mannoprotein to the 
D
ow
nl
oa
de
d 
by
 [U
C
L 
Li
br
ar
y 
Se
rv
ic
es
] a
t 0
0:
45
 3
0 
O
ct
ob
er
 2
01
7 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 18 
binding of opsonising antibody, thereby increasing phagocyte recognition and 
phagocytosis, as has previously been reported for acapsular mutants 43. 
Interestingly, less apparent alteration in cell wall organization was detected in kcs1Δ by 
TEM analysis as compared to arg1Δ. This was despite kcs1Δ displaying a more severe 
growth defect in the presence of cell wall perturbing reagents. Compensatory changes, 
such as alteration of cell wall architecture, may therefore be essential for maintaining 
the viability of arg1Δ. As the absence of Kcs1 is less detrimental, resulting in loss of 
only PP-IP5-dependent functions, the compensatory changes are less apparent, or not 
required, in kcs1Δ. Compensatory changes in the cell wall have been reported in other 
fungi where cell wall stress caused by mutations or antifungal drugs, triggered 
increased deposition of chitin in the cell wall 44, 45, 46.  
In contrast to arg1Δ, Plb1 protein was barely detectable in kcs1Δ despite the PLB1 
mRNA level being similar to that of the WT (Fig. 8). Why Plb1 protein production is 
reduced in kcs1Δ, but not in arg1Δ is unknown but is most likely due to  a defect in 
translation of the PLB1 mRNA. In our previous publication23, we demonstrated that 
exposure of mannoproteins on the surface of the kcs1∆ mutant, as detected by 
concanavalin A binding, was reduced, and that this coincided with the reduced 
expression of a subset of mannoprotein-encoding genes. RNAseq analysis also shows 
that expression of these mannoproteins, but not Plb1, is reduced in the arg1∆ mutant 
(GEO accession GSE78824). We propose that expression of other mannoproteins, 
including Plb1, could be upregulated in the arg1Δ mutant (but not in the kcs1Δ mutant) 
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in an attempt to compensate for a defective cell wall, with Plb1 being more highly 
associated with the cell periphery. 
 
We propose that excess IP3 and/or the absence of IP4/IP5 are likely to contribute to the 
PP-IP5-independent phenotypes observed in arg1Δ. An excess of IP3 might be 
detrimental by competing with phosphoinositides and IPs for binding to the pleckstrin 
homology (PH) domain, and/or other specialized protein domains, thus interfering with 
the regulation of their functions 47, 48. Alternatively, an excess of IP3 could potentially 
inhibit Plc1 activity via feedback inhibition, since IP3 is a product of Plc1-mediated PIP2 
hydrolysis 20. In support of this, the PLC1 deletion mutant (plc1Δ) and the arg1Δ mutant 
have a similar phenotype, including cell walls with abnormal morphology, blocked 
release of Plb1 from the cell periphery and rapid pulmonary clearance in a mouse 
model 34, which are all PP-IP5 independent. The absence of IP4 could affect gene 
expression since IP4 is required for the incorporation of the histone deacetylase HDAC3 
into a repressive complex, and for its enzymatic activity in mammalian cells 49, 50. Both 
IP4 and IP5 have been reported to bind to PH domains 49, 50, 51, 52.  Hence the absence of 
IP4/IP5 in the arg1Δ mutant could affect the function of proteins containing PH domains. 
 
In summary, the combination of PP-IP5 -dependent and -independent functions render 
Arg1 the most important IPK for the virulence of C. neoformans in animal models. Its 
PP-IP5-independent roles in regulating cryptococcal surface topology likely affect 
recognition by the host immune system, resulting in clearance in mouse models. The 
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key role of Arg1 in virulence, coupled with its low sequence similarity and non-
redundant function as compared to mammalian cells, make Arg1 a candidate target for 
antifungal drug development.  
 
Material and methods 
 
Fungal strains and media 
Cryptococcal strains used in this study were wild-type (WT) C. neoformans var. grubii 
strain H99 (serotype A, MATα) and the isogenic strains, arg1Δ, kcs1Δ and reconstituted 
arg1Δ (arg1Δ + ARG1), which were created as previously described in 20, 23. Strains 
were routinely grown on YPD (1% yeast extract, 2% peptone and 2% dextrose) or 
Sabouraud (SAB) agar (1% peptone, 4% glucose, 1.5-2% agar). The S. cerevisiae 
deletion mutants, arg82Δ (#4003531) and kcs1Δ (#4003956), which were derived from 
the parental strain BY4741, were obtained from the ATCC. 
 
Expression, purification and enzymatic characterisation of recombinant Arg1 
Arg1 cDNA was amplified using primers ARG1-BgIII -s 
(tacgagatctGACCTGCCCCTCACCCTCG) and ARG-EcoRI-a 
(CAAGGAATTCTCAAACACAACCCCGTTCAACC) and cloned into the pRSET 
expression vector to allow production of a 6 histidine-tagged Arg1 fusion protein in 
Rosetta™ (DE3) E. coli strain. Cultures were incubated overnight at 37°C, diluted 1:100 
and incubated at 37°C until the OD600 reached 0.6-0.8. 1 mM IPTG was then added to 
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induce expression of His-tagged Arg1 and the cultures were incubated overnight at 
ambient temperature. The cells were washed with water, resuspended in lysis buffer 
(500 mM NaCl; 25 mM Tris–HCl pH 8.0), sonicated and centrifuged to remove debris.  
 
His-Arg1 fusion protein in the supernatant then underwent two rounds of purification. 
The first round involved using a His GraviTrap TALON affinity column (GE Healthcare, 
Cat. No. 29-0005-94). The column loaded with His-Arg1 was washed with 10 mL of 
wash buffer I (600 mM NaCl; 0.1% (v/v) Trition X-100; 25 mM Tris–HCl pH 8.0), and 
then with 10 mL of wash buffer II (100 mM NaCl; 0.1% (v/v) Trition X-100; 25 mM Tris–
HCl pH 7.4). His-Arg1 was eluted from the column with the elution buffer (100 mM NaCl, 
200 mM imidazole, 25 mM Tris pH 7.5). His-Arg1 protein was then diluted 3.5-fold in a 
buffer containing 20 mM Tris pH 7.4, 1 mM DTT and 1 mM MgSO4 and concentrated 
using an Amicon concentrator (10 kDa cutoff). The second round of purification involved 
using an anion exchange column; His-Arg1 was eluted from this column using a NaCl 
gradient (buffer A: 30 mM NaCl, 20 mM Tris pH 7.4, 1 mM MgSO4, 1 mM DTT; buffer B: 
similar to A, but with NaCl 1000 mM). The purified His-Arg protein was then diluted in a 
storage buffer (100 mM NaCl; 1 mM MgSO4; 1 mM DTT; 0.05% (v/v) CHAPS; 20 mM 
Tris–HCl pH 7.4, 40% glycerol) at 500 μg/mL, snap-frozen and stored in aliquots at -
80°C. 
 
Routinely, Arg1 activity assay (10 μL) contained 5 μL 2X reaction buffer (40 mM Hepes 
pH 6.8; 200 mM NaCl; 12 mM MgCl; 2 mM DTT), 200 μM IP3, 500 μM ATP and 20 ng 
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purified Arg1. The reactions were incubated at ambient temperature for up to 30 min, 
and ATP consumption was measured using a bioluminescent ATP assay kit (Kinase-
Glo® Max Luminescent Kinase Assay Kit, Promega). To determine the kinetic 
properties of Arg1, the reactions were performed using starting ATP concentrations 
ranging between 50-500 μM ATP, and the ATP concentration was assessed after 0, 10, 
20 and 30 min. The assay was performed twice, each in triplicate. Km and Vmax were 
determined using the Michaelis-Menten model.  
 
To establish that Arg1 is an IP3-4 kinase using PAGE, 40 μl reactions were set up as 
described above, using different final concentrations of Arg1 (1 to 10 ng/μl). The 
reactions were terminated after 10 min, 20 min or 2 hours, as indicated in Figure 3, by 
the addition of EDTA (10 mM). Visualization of IPs (Arg1 substrates/products) using 
PAGE and Toluidine Blue staining was performed as described in 53. 
 
Yeast complementation assay 
ARG1 cDNA from C. neoformans was amplified using the forward primer 
ccaactagtATGGACCTGCCCCTCACCCT and reverse primer 
cgcttaattaaTCAAACACAACCCCGTTCAAC, and cloned into the pESC-LEU expression 
vector. The vectors were used to transform strain BY4741 (S. cerevisiae) and the arg1Δ 
mutant using a Frozen-EZ Yeast Transformation II Kit (Zymo Research).  
Complemented and control strains were tested by growing on standard SD medium 
without leucine at high temperature (39°C) or in the presence of 0.1 mg/mL Calcofluor 
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white (CFW) or 0.0075% SDS. To test growth on different nitrogen sources, SD was 
prepared without amino acids and ammonium sulfate, and supplemented with ornithine 
or ammonium sulfate as the sole nitrogen source.  Stress tolerance of the S. cerevisiae 
and C. neoformans mutant and WT strains was compared on YPD plates supplemented 
with 0.8M NaCl or incubated at 37°C. 
 
Virulence studies 
This study was approved and performed in accordance with the recommendations and 
guidelines of the Western Sydney Local Health District Animal Ethics Committee, 
Department of Animal Care, Westmead Hospital. The virulence of the strains in 7-week-
old female BALB/c mice (from the Animal Resource Centre, Floreat Park, Western 
Australia) was tested as previously described 24.  
Survival: 10 mice/group were inoculated intranasally with either the WT, arg1Δ or the 
arg1Δ + ARG1 strain (5 x 105 cells/20 μL PBS), observed daily for signs of infection over 
a 60-day period, and sacrificed at predetermined clinical endpoints. 
Organ burden: 3 mice/group were inoculated intranasally with either the WT or the 
arg1Δ strain, and lung and brain were collected at 3, 7 and 14 days post infection to 
assess fungal load and histopathology.  
Histopathology: Lungs were removed and fixed in 4% formalin. Sections (5 μm) were 
cut with a microtome and stained with Periodic Acid–Schiff (PAS) stain to identify 
infecting C. neoformans cells. Images were obtained as various magnifications using an 
Olympus BX43 light microscope fitted with an Olympus DP21 digital camera. 
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Phagocytosis assay 
Fungal cells were grown overnight in YPD broth, washed with water, and heat-killed by 
incubating at 56°C for 30 min to prevent replication. Cells were then labelled with 0.5 
mg/mL FITC (Sigma) in PBS for 30 min. Excess stain was removed by washing 4 times 
with PBS and the final cell pellet was resuspended in PBS. FITC-labeled fungal cells 
were opsonized for 30 min by incubation with 10% human serum in PBS (106 cells/100 
μL), pelleted, and then resuspended in RPMI 1640-10% FBS medium. 
 
Peripheral blood mononuclear cells (PBMCs) were isolated from a25 mL human blood 
using Ficoll-Paque PLUS (GE Healthcare) following the manufacturer’s instructions. The 
PBMC layer was extracted and resuspended in RPMI/10% FBS. PBMCs (4 x 106) were 
mixed with cryptococci (4 x 106) in 1:1 ratio in 100 μL of RPMI 1640-10% FBS medium, 
and co-incubation was allowed for 2 h at 37°C/5% CO2. 
 
The co-culture was washed once with PBS, and treated with 50 μg Fc blocking agent 
(mouse IgG Life Technologies, Cat. No. 02-6502; prepared working solution of 100 
μg/mL in 0.5% BSA PBS with 0.05% sodium azide). The monocytes in the PBMC 
population were labelled with anti-CD14 BV421-conjugated antibodies (BioLegend, Cat. 
No. 301830). The extent of phagocytosis in 50 μL of the co-culture was determined by 
flow cytometry (BD FACSCanto™ II). 
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Comparing cell-associated and secreted Plb1 protein by Western blotting 
Each strain was cultured overnight in YNB + 2% glucose. The cultures were adjusted to 
equal cell numbers and grown for a further 18 hours. Equal cell numbers were pelleted 
by centrifugation and the supernatants (protein secretions) were collected and dialyzed 
using SnakeSkin® Dialysis Tubing with a 10K molecular weight cut-off (Thermo Fisher 
Scientific). The dialyzed supernatants were snap-frozen in liquid nitrogen before being 
lyophilized within a Christ Alpha 2-4 freeze dryer (Martin Christ, Osterode, Germany). 
The dried pellets were then resuspended in 125 mM imidazole buffer (pH 4.0) and 
precipitated with 90% trichloroacetic acid (TCA).  
 
Total protein and RNA from the cell pellets were extracted with TRIzol® (Thermo Fisher 
Scientific, Cat. No. 15596026) and used to assess the level of cell-associated Plb1 
protein and PLB1 mRNA, respectively. Briefly, the fungal cell pellets were resuspended 
in TRizol® and homogenized in the presence of glass beads (426-600 μm, Sigma) 
using a bead beater (4 cycles, 30 sec beating, 1 min rest). After homogenization, RNA 
and protein were prepared according to the manufacturer’s instructions.  
 
Proteins in the secreted and cell-associated fractions were dissolved in NuPAGE® 
sample loading buffer and reducing agent (Life Technologies). They were then resolved 
by SDS-PAGE using NuPAGE® 4-12% bis-Tris gels (Life Technologies) at 170V for 55 
min, and transferred to a PVDF membrane (Immobilon-P 0.45 μm transfer membrane, 
Millipore). To detect Plb1 protein the blots were incubated with an anti-Plb1 peptide 
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specific antibody: 1 μg/mL in Tris-buffered saline with 0.05% Tween-20 (TBST) and 2% 
BSA. Production of anti-CnPlb1 antibody was described in 54. The membranes were 
washed four times with TBST and then incubated with donkey-anti-goat secondary 
antibody (Santa Cruz Biotechnology), diluted 1:5000 in TBST with 2% BSA. 
Chemiluminescence was detected by exposing the membrane to Amersham 
Hyperfilm™ ECL (GE Healthcare) and developing the film using an X-ray developer.  
 
PLB1 gene expression 
Total RNA extracted as described above was treated with DNase and used for oligo-dT-
primed cDNA synthesis. The primer pairs for amplifying PLB1 (target gene) and ACT1 
(reference gene) cDNA were prepared at a final concentration of 2 μM each. Primer 
sequences were for a) PLB1: TCATTAGCGCACCGAGTTTG (forward) and 
AATGGCAAGTGGTGGTAGCC (reverse) and b) ACT1: ATGGTATTGCCGACCGTATG 
(forward) and CTCTTCGCGATCCACATCTG (reverse). PLB1 gene expression levels in 
each sample, relative to ACT1, were then determined using SYBR Green qRT-PCR 
(Corbett Rotor-Gene 6000). Relative quantification of PLB1 expression was determined 
using the ΔΔCt method 55.  
 
Enzymatic removal of N-linked glycans 
Secretions containing 40 μg protein were resuspended in 25 μL 20 mM sodium 
phosphate buffer (pH 7.5) and treated with 2U PNGase F (New England Biolabs 
P0704S). A PNGase F negative control was prepared by substituting PNGase F with 2 
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μL 20 mM sodium phosphate buffer. Samples were incubated at 37°C for 18 hours, 
after which they were dried using an Eppendorf Concentrator. Samples were then 
subjected to SDS-PAGE and then either stained for glycoproteins according to the 
manufacturer’s instructions (Pierce Glycoprotein Staining Kit, catalogue number 24562) 
or subjected to Western blotting as per the Plb1 Western blotting protocol above.  
 
Microscopy 
Sample preparation for Transmission Electron Microscopy was carried out as described 
in 34. Briefly, overnight YPD cultures of C. neoformans were prepared for TEM using 2% 
glutaraldehyde pre-fixation and 2% KMnO4 post-fixation. Following resuspension in 1:1 
acetone:epoxy resin, cell pellets were embedded in 100% epoxy resin. 60–80 nm 
sections were cut using the Leica Ultracut UCT ultramicrotome (Leica Microsystems, 
Bannockburn, IL), stained with uranyl acetate-lead citrate and viewed with a JEM 
1200EX transmission electron microscope (JEOL, USA). 
Vacuole labeling with FM 4-64 was carried out as described in 20. Briefly, cells were 
grown in YPD overnight, pelleted and resuspended in fresh medium (1 ml, OD600 ~0.5). 
After addition of FM 4-64 (10 μM final concentration), the cells were stained for 5 min, 
pelleted, resuspended in fresh YPD medium and incubated for an additional 40 min at 
30°C with shaking. The tubes were stored on ice until visualization. 
 
Statistical analysis 
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Statistical analysis was carried out using SPSS Statistics software (version 24). 
Specifically, the Kaplan Meier Log-ranked Mantel-Cox test and the Mann-Whitney U test 
were used to assess survival and organ burden differences, respectively, in the mice 
studies. One-way analysis of variance (ANOVA) followed by Tukey-Kramer multiple 
comparison was used to assess PLB1 gene expression levels and phagocytosis. 
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Figure 1. Arg1 from C. neoformans restores defective phenotypes in the S. cerevisiae 
arg82Δ mutant. ARG1 cDNA was cloned into the pESC-LEU vector, which was then 
used to transform the S. cerevisiae arg82Δ mutant. Cells containing cloned ARG1 or 
empty vector were spotted onto plates containing the various media, as indicated, from 
106 cells per drop to 10 cells per drop.  Plates were incubated at either 30°C or 39°C.  
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Figure 2. Arg1 and Arg82 differentially contribute to stress adaptation of C. neoformans 
and S. cerevisiae. WT and the indicated mutant strains were spotted onto plates 
containing the various media, as indicated, from 106 cells per drop to 10 cells per drop, 
and incubated for 2-4 days. 
 
Figure 3.   Purified Arg1 specifically phosphorylates IP3 to produce IP4 and IP5. (A) 
Recombinant Arg1 (49 kDa, including the His6  tag) was purified by TALON cobalt 
affinity chromatography followed by ion exchange chromatography (IEC). (B) Purified 
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Arg1 (1-10 ng/μl reaction, as indicated) was incubated with ATP and IP3 and the 
reaction products analyzed by polyacrylamide gel electrophoresis and Toluidine Blue 
staining. Bands representing different IP species and ATP are indicated. (C) Kinetics of 
Arg1 activity. For these assays, purified Arg1 (20 ng) was incubated with ATP (50-500 
μM) and 200 μM of IP3 in 10 μL reactions at room temperature for 0-30 min. The 
consumption of ATP was monitored using bioluminescence. The assay was performed 
twice, each time in triplicate. V: reaction velocity. 
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Figure 4. Comparative phenotypic testing of arg1Δ and kcs1Δ. WT, mutant and 
reconstituted strains were spotted onto plates containing the various media as 
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indicated, from 106 cells per drop to 10 cells per drop, and incubated for 2-4 days. 
 
Figure 5. Transmission electron microscopy (TEM) demonstrating that arg1Δ cell walls 
are thicker than, and structurally different to, those of WT and kcs1Δ, and that arg1Δ 
cells have larger vacuoles. N: nucleus; CW: cell wall; V: vacuole.  
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Figure 6. arg1Δ cells, but not kcs1Δ cells, are enlarged and produce bigger vacuoles. 
Cells were allowed to endocytose the lipophilic dye, FM 4-64, for 40 min to label 
vacuoles (indicated by arrows in panels on the right). Differential interference contrast 
images are shown on the left.  
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Figure 7. arg1Δ and kcs1Δ capsule size is reduced and increased, respectively, relative 
to WT. Cells were grown in minimal medium (broth) overnight. Capsules were visualized 
with India Ink stain under a light microscope at 100X magnification. The graph 
represents the mean ratio of capsule width to cell body diameter in each strain ± 
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standard deviation (n= 51 cells). ***, P<0.001 using a Tukey-Kramer multiple 
comparison test.  
 
Figure 8.  Blocked secretion of Plb1 in arg1Δ coincides with an increase in Plb1 
molecular weight as assessed by Western blotting. (A) Plb1 in secretions and cell 
lysates was resolved by SDS-PAGE and detected using anti-Plb1 antibody. (B) PLB1 
gene expression was quantified by qPCR. The results are the average of three 
biological replicates ± SD.   **, P < 0.01; ***, P < 0.001; n.s, not significant.  
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Figure 9.  N-linked mannosylation of Plb1 and secretome composition are altered in 
arg1Δ. Cryptococcal secretions, each containing 40 μg of protein, were collected from 
WT and arg1Δ, treated with PNGase F (+), resolved by SDS-PAGE and subjected to 
either (A) anti-Plb1 Western blotting, (B) glycoprotein staining or (C) glycoprotein 
staining followed by Commassie staining. In (C), the arrow indicates the position of the 
PNGase F enzyme. 
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Figure 10.  Arg1 is essential for lung colonization and dissemination in a murine 
inhalation model of cryptococcosis. (A) arg1Δ is avirulent compared to WT and arg1Δ + 
ARG1. Mice (n=10 per strain) were inoculated intranasally with 5 x 105 cells/20 μL and 
monitored daily. Difference in survival between WT/arg1Δ + ARG1-infected mice and 
arg1Δ-infected mice is statistically significant (**** P < 0.0001). (B) and (C) arg1Δ 
infection is rapidly cleared from mouse lung between 3 and 7 days post-infection. Mice 
(n=3 per strain) were inoculated intranasally with 5 x 105 cells/20 μL and sacrificed on 
the days indicated. Lung and brain were harvested for quantitative culture (CFUs) (B) or 
histopathological analysis for lung only by Periodic acid–Schiff (PAS) staining (C). In 
(B), the difference in lung CFUs for WT and arg1Δ-infected mice at day 3 is statistically 
significant (* P < 0.05).  In (C), lung histopathology is shown at 3 days post-infection 
(PAS stain, 40x magnification). In WT-infected lung tissue, arrows indicate 
cryptococcomas where capsular material is represented by white halos surrounding the 
cell bodies (stained magenta). In arg1Δ-infected tissue, arrows indicate single acapsular 
cryptococcal cells.  
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Figure 11. arg1Δ is more readily phagocytosed by human PBMCs. Results are 
expressed as the mean % of CD14+ monocytes containing FITC-labelled C. neoformans 
± SD (n=3). Statistical significance is indicated as follows: *** P < 0.001.  
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Figure 12. Summary of PP-IP5-dependent and –independent functions of Arg1 (A), and 
the contribution of Arg1 and Kcs1 to virulence (B). pH – alkaline pH stress; CW – cell 
wall stress induced by calcofluor white, Congo red, SDS, caffeine; ER – endoplasmic 
reticulum stress caused by tunicamycin and DTT; PHO – phosphate deprivation; OS/NS 
– oxidative and nitrosative stress, respectively. 
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